Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1984-6-19
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0047-1852
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
416-21
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:6143840-Adrenergic alpha-Antagonists,
pubmed-meshheading:6143840-Adrenergic beta-Antagonists,
pubmed-meshheading:6143840-Drug Resistance,
pubmed-meshheading:6143840-Heart Rate,
pubmed-meshheading:6143840-Humans,
pubmed-meshheading:6143840-Hypertension,
pubmed-meshheading:6143840-Myocardial Contraction
|
pubmed:year |
1984
|
pubmed:articleTitle |
[alpha and beta Blockaders for the management of hypertension].
|
pubmed:publicationType |
Journal Article
|